4-Year Check-In: how do COVID-19 ICU survivors fare?

NCT ID NCT07397156

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 283 adults who needed intensive care for severe COVID-19 lung damage (ARDS) in Poland. Researchers tracked who survived up to 4 years later and asked survivors about their quality of life, breathing, and daily function. No new treatment was tested—the goal was simply to understand long-term outcomes after such a serious illness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal long-term health challenges and recovery patterns after severe COVID-19, helping guide future care and rehabilitation.

What could go wrong

This is an observational study with no experimental treatment, so it cannot prove what causes outcomes. Results come from a single center in Poland and may not apply to other populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lung injury acute respiratory distress syndrome COVID-19 Financial Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University in Zielona Góra

    Zielona Góra, Lubusz Voivodeship, Poland